(Q43091449)
Statements
1 reference
Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer (English)
1 reference
1 reference
José-María Roca
1 reference
Vicente Alonso
1 reference
Pilar Escudero
1 reference
Antonieta Salud
1 reference
Ferrán Losa
1 reference
Luis-Jesús López
1 reference
Imma Guasch
1 reference
Miguel Méndez
1 reference
Guillermo Quintero-Aldana
1 reference
Carlos Grande
1 reference
Pilar Vicente
1 reference
Antonio Arrivi
1 reference
Cristina Martin
1 reference
Isabel Moreno
1 reference
Pilar García
1 reference
Isabel Antón
1 reference
Manuel Constenla
1 reference
Alfonso Yubero
1 reference
Luis Cirera
1 reference
ACROSS Cooperative Group
1 reference
21 April 2010
1 reference
1 reference
56
1 reference
2
1 reference
142-146
1 reference
Identifiers
1 reference
1 reference